Tocilizumab-induced erythroderma.
Nakamura
Motonobu
M
Tokura
Yoshiki
Y
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C502936:tocilizumab